Senior Director, Country Manager

About Revolution Medicines: Revolution Medicines is an elite, late-stage clinical oncology company completely dedicated to developing novel targeted therapies for patients with RAS-addicted cancers. The enterprise’s deep R&D pipeline comprises next-generation RAS(ON) inhibitors engineered to suppress diverse oncogenic variants of RAS proteins. Currently in active clinical development are several selective small-molecule inhibitors, including daraxonrasib (RMC-6236), elironrasib (RMC-6291), and zoldonrasib (RMC-9805). Our team consists of outstanding scientific and medical professionals united by a tireless commitment to advancing cancer treatment frameworks and identifying breakthroughs for oncology profiles globally.

Position Overview

We are seeking a highly strategic, business-fluent, and leadership-driven Senior Director, Country Manager, Poland to spearhead our commercial operations and expansion infrastructure under a permanent, full-time remote configuration based within Poland. Reporting directly to the Vice President, General Manager, Mid-Sized Markets of Europe, you will claim absolute P&L ownership, market access design, and cross-functional team build-out accountability across the Polish territory. Shifting completely away from routine standalone data entry transcribing, generic helpdesk IT ticketing, or non-technical support workflows, you will run an active corporate governance, pre-launch market positioning, and distributor contract negotiation laboratory—partnering face-to-face with regional executive boards and local regulatory bodies. This position requires an executive pharmaceutical authority with 15+ years of oncology leadership experience who structures market entry tracks fluidly natively using Project Management paradigms, evaluates pricing and reimbursement parameters cleanly within the Polish pharmaceutical ecosystem, establishes country-specific standard operating procedures (SOPs) systematically, and guides cross-functional business cells confidently to accelerate clinical-stage assets to market.

Key Responsibilities

• Country Operations & P&L Governance: Direct, monitor, and optimize the comprehensive profit-and-loss (P&L) balance sheet and operational budgets for Poland, ensuring strategic resource allocation natively utilizing Project Management frameworks.
• Commercial Launch Engineering: Lead the planning, positioning, and execution of elite product launches across Poland, orchestrating early access programs, pricing, and market access strategies.
• Cross-Functional Team Building: Recruit, lead, and develop a high-performing cross-functional country team, collaborating with global functional leaders to align localized operations with corporate milestones.
• Distributor & Vendor Contract Management: Partner alongside internal Finance, Legal, and Commercial units to manage selection processes and negotiate complex legal agreements with local pharmaceutical distributors.
• Clinical Site Selection Support: Provide regional operational oversight for clinical trial site selections, enrollment parameters, and quality assurance checkpoints to meet local regulatory thresholds.
• Regulatory & SOP Compliance: Establish robust country risk management frameworks, compliance baselines, and local SOPs, ensuring all business actions strictly fulfill domestic Polish laws.

Required Skills & Qualifications

• Possess a formal Advanced Degree (Master, Ph.D., or MBA) centered within life sciences, business administration, or an identical quantitative executive field.
• A minimum of 15+ years of verified, progressive professional history operating inside senior leadership positions within the biopharmaceutical industry.
• Mandatory Oncology & Territory Expertise: Deep, non-negotiable history launching specialized drugs within the oncology field in Poland , coupled with previous proven experience operating as a Country Manager within the Polish pharmaceutical market.
• Granular command over the Polish healthcare ecosystem, including in-depth mastery of local market access pathways, pricing mechanisms, and early access structures.
• Complete bilingual fluency in written and verbal English and Polish languages.
• Location Context: Position operates under remote parameters open exclusively to qualified pharmaceutical executives residing permanently inside Poland .

Preferred Strategic Indicators (Nice to Have)

• Prior experience steering operations within an entrepreneurial, fast-growing commercial biotech environment.
• Proven capacity to roll up the sleeves and execute hands-on process build-outs inside lean regional startup infrastructures.
• Pre-existing relationship networks with Polish healthcare authorities, key opinion leaders, and regional market access stakeholders.

What We Offer

• Top-Tier Executive European Remuneration: A highly competitive, senior-level annual salary package calibrated to experience and country benchmarks, supplemented by extensive stock option access, performance milestones, and global incentives.
• 100% remote workspace flexibility across Poland, paired with autonomous territory lifecycle planning control.
• Direct operational credentials built by heading a critical mid-sized European expansion branch for a late-stage oncology pioneer.
• Comprehensive health care, lifestyle assurance frameworks, and professional parameters benchmarked cleanly to lead corporate European baselines.
• Access to a collaborative, authentic organizational culture that fosters entrepreneurial execution while delivering revolutionary oncology therapeutics to patients in need.